tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eddie Hickman, 7 are a BUY (100%).
Analyst Eddie Hickman, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 55.56% that have a potential upside of 100.19% achieved within 251 days.
Eddie Hickman’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 25-Jan-2024.
Analyst best performing recommendations are on ISEE (IVERIC BIO).
The best stock recommendation documented was for ISEE (IVERIC BIO) at 9/7/2022. The price target of $35 was fulfilled within 236 days with a profit of $20.06 (134.27%) receiving and performance score of 5.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$40
1 years 6 months ago
(08-May-2023)
4/5 (80%)
$8.4 (26.58%)
470
Hold
$34
$-5.95 (-14.89%)
$26
1 years 6 months 5 days ago
(03-May-2023)
2/3 (66.67%)
$-3.21 (-8.63%)
116
Hold
$35
$-4.95 (-12.39%)
$35
1 years 6 months 6 days ago
(02-May-2023)
5/6 (83.33%)
$-2.72 (-7.21%)
247
Hold
$35
$-4.95 (-12.39%)
$29
1 years 6 months 7 days ago
(01-May-2023)
1/2 (50%)
$-3.05 (-8.02%)
15
Buy
$35
$-4.95 (-12.39%)
$30
1 years 6 months 15 days ago
(24-Apr-2023)
3/3 (100%)
$3.34 (10.55%)
240
What Year was the first public recommendation made by Eddie Hickman?
